Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Genmab A/S ADR (GMAB)
Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,379,442
  • Shares Outstanding, K 660,675
  • Annual Sales, $ 2,067 M
  • Annual Income, $ 781,920 K
  • 60-Month Beta 1.01
  • Price/Sales 10.28
  • Price/Cash Flow 24.77
  • Price/Book 4.55
Trade GMAB with:

Options Overview Details

View History
  • Implied Volatility 16.14% ( -11.62%)
  • Historical Volatility 34.33%
  • IV Percentile 3%
  • IV Rank 2.50%
  • IV High 66.32% on 03/15/23
  • IV Low 14.85% on 10/25/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 633
  • Open Int (30-Day) 728

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.33
  • Number of Estimates 7
  • High Estimate 0.52
  • Low Estimate 0.25
  • Prior Year 0.12
  • Growth Rate Est. (year over year) +175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.20 +6.89%
on 11/28/23
32.89 -1.85%
on 11/17/23
+1.28 (+4.13%)
since 11/08/23
3-Month
27.74 +16.37%
on 11/02/23
38.80 -16.80%
on 09/14/23
-5.51 (-14.58%)
since 09/08/23
52-Week
27.74 +16.37%
on 11/02/23
47.12 -31.50%
on 12/12/22
-13.56 (-29.58%)
since 12/08/22

Most Recent Stories

More News
3 Solid Biotech Buys for a Healthy Year-End Portfolio

The growing adoption of AI technologies by biopharmaceutical companies and the increasing government initiatives worldwide are expected to boost the biotech industry. Therefore, it could be wise to buy...

ALNY : 170.04 (-4.07%)
GMAB : 32.28 (-0.25%)
INVA : 15.12 (+2.44%)
3 Biotech Stocks Bursting With Investment Potential

The biotech industry is well-positioned for robust growth thanks to the increasing demand for effective treatments for chronic diseases and the need to serve an aging population. To capitalize on the favorable...

GMAB : 32.28 (-0.25%)
INCY : 54.70 (-0.87%)
ORGO : 3.33 (+18.51%)
3 Biotech Stocks to Watch in November

The biotech industry’s expansion stems from advancements in bio-medical drug development and cutting-edge technology. Given these factors, prominent biotech stocks Inovio Pharmaceuticals (INO), Surrozen...

GMAB : 32.28 (-0.25%)
INO : 0.3800 (+0.53%)
SRZN : 0.5200 (-3.85%)
Why Shares of Iovance Biotherapeutics Dropped Thursday

The biotech stock's lead therapy is looking at some competition.

SGEN : 218.98 (+0.30%)
GMAB : 32.28 (-0.25%)
IOVA : 6.40 (-4.90%)
Why Shares of Zai Lab Limited Were Jumping on Tuesday

Zai Lab's shares benefited from positive clinical trial news.

ZLAB : 27.29 (-0.76%)
SGEN : 218.98 (+0.30%)
GMAB : 32.28 (-0.25%)
Is AbbVie Still a Good Dividend Stock to Buy?

Find out if AbbVie can overcome sinking sales of its top-selling product.

ABT : 104.51 (+0.44%)
RHHBY : 36.0000 (+1.18%)
AMGN : 269.12 (-0.81%)
GMAB : 32.28 (-0.25%)
ABBV : 149.28 (+0.89%)
3 Things About Johnson & Johnson Every Smart Investor Knows

The company has been a strong value stock but faces big changes this year.

KVUE : 20.61 (-0.96%)
AMGN : 269.12 (-0.81%)
GMAB : 32.28 (-0.25%)
JNJ : 154.42 (-0.63%)
Is AbbVie (ABBV) a Better Stock to Buy Than Pfizer (PFE)?

Due to the emergence of new technologies and the introduction of generic medicines, the pharma industry seems well-positioned to witness growth. While pharma stocks should benefit from the industry tailwinds,...

ABBV : 149.28 (+0.89%)
GMAB : 32.28 (-0.25%)
OPK : 1.6300 (+1.87%)
PFE : 28.78 (+0.52%)
Invest in These 3 High-Growth Biotech Stocks

Technological improvements, government, and private investment, and favorable regulatory policies are propelling the biotech industry’s growth and offering breakthrough cures and products. With the industry...

GMAB : 32.28 (-0.25%)
INCY : 54.70 (-0.87%)
LVTX : 1.5500 (+1.31%)
Could This New Drug Be a Blockbuster for These 2 Pharma Collaborators?

In May, the FDA approved epcoritamab, developed by AbbVie and Genmab, as a treatment for a type of blood cancer.

ABBV : 149.28 (+0.89%)
GMAB : 32.28 (-0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 33.09
2nd Resistance Point 32.87
1st Resistance Point 32.57
Last Price 32.28
1st Support Level 32.06
2nd Support Level 31.85
3rd Support Level 31.55

See More

52-Week High 47.12
Fibonacci 61.8% 39.72
Fibonacci 50% 37.43
Fibonacci 38.2% 35.14
Last Price 32.28
52-Week Low 27.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar